Understanding these risks is the first step toward creating a cleaner, safer future. Researchers make alarming new discovery ...

Freyr Battery (NYSE:FREY) has informed officials in a suburban Atlanta county that it won’t proceed with a $2.6B plant, the Newnan Times Herald reported Thursday. According to the report, the ...

A recent study from the Earth-Life Science Institute (ELSI) investigates how polyester microdroplets, potential precursors to modern cells, could form under realistic early Earth conditions.

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...

By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia - a bulge that results from soft tissue pushing through a weak spot in the abdominal muscles.

Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, ...

By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia. Although common, the cause of these hernias is unknown, and the only treatment is surgery to repair the weakened area. Even after ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

It's not the only blood pressure medication recall to happen in recent months, but the FDA's concern appears to follow a common theme.

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company ...